AlphaMark Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
AlphaMark Advisors's IBB Position: Q4 2024 in Review
AlphaMark Advisors held its iShares Biotechnology ETF (IBB) position steady in Q4 2024 at 50 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #480.
AlphaMark Advisors first reported a position in IBB in Q2 2013 and has held it in 23 quarters since. The position peaked at $158K in Q2 2014. 875 funds tracked by Wall St. Rank hold IBB as of Q4 2024.
- AlphaMark Advisors held 50 shares of iShares Biotechnology ETF worth $7K as of Q4 2024.
- AlphaMark Advisors left its iShares Biotechnology ETF share count unchanged in Q4 2024.
- iShares Biotechnology ETF made up ﹤0.01% of AlphaMark Advisors's portfolio in Q4 2024, its #480 holding.
- AlphaMark Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 23 quarters since.
- AlphaMark Advisors's iShares Biotechnology ETF position peaked at $158K in Q2 2014.
- 875 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.
Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.